# Newsletter

```json
{
  "title": "LAI Intelligence Weekly – 2025-12-09",
  "intro": "This week's intelligence covers critical developments across the LAI ecosystem, with major players advancing competitive positioning in hemophilia, inflammatory diseases, and rare conditions. Regulatory actions and strategic partnerships are reshaping the landscape, while pharma companies explore novel awareness campaigns. The period analyzed 50 items spanning December 2-9, 2025.",
  "tldr": [
    "Pfizer presents phase 3 H

*Newsletter générée par Vectora Inbox – Powered by Amazon Bedrock*
